Berger Franklin M

Berger Franklin M is listed in filings as Director at Kezar Life Sciences, Inc.. This profile follows SEC Form 4 activity through May 11, 2026, including purchase activity and sale activity. Recent filings connect the profile to Kezar Life Sciences, Inc. (KZR), ESSA Pharma Inc. (EPIX), and Atea Pharmaceuticals, Inc. (AVIR). The current snapshot covers public activity from Jun 18, 2024 to May 11, 2026. Reported amounts are shown as $619.5K to $59.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.